BIOTEST ANTI-EBV RECOMBINANT— 510(k) K983839

Substantially Equivalent

Biotest Diagnostics Corp.

FDA 510(k) clearance K983839 for BIOTEST ANTI-EBV RECOMBINANT, Substantially Equivalent on 1999-06-09. Applicant: Biotest Diagnostics Corp..

Clearance details

Applicant: Biotest Diagnostics Corp.
Product code: Code LSE
Advisory panel: Microbiology
Date received: 1998-10-30
Decision date: 1999-06-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Denville, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.